| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PHAR.1961 |
| P698 | PubMed publication ID | 28555946 |
| P2093 | author name string | Todd A Lee | |
| Surrey M Walton | |||
| Robert J DiDomenico | |||
| Kibum Kim | |||
| Daniel R Touchette | |||
| Amer K Ardati | |||
| P2860 | cites work | Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin | Q28195019 |
| ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction | Q28240355 | ||
| Ticagrelor versus clopidogrel in patients with acute coronary syndromes | Q29619002 | ||
| Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data | Q31011382 | ||
| Economic burden of illness of acute coronary syndromes: medical and productivity costs | Q33818788 | ||
| A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data | Q34133867 | ||
| First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies. | Q34149952 | ||
| An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association | Q34343431 | ||
| Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome | Q34748390 | ||
| Validity of hospital discharge diagnosis codes for stroke: the Atherosclerosis Risk in Communities Study | Q34916044 | ||
| Validity of myocardial infarction diagnoses in administrative databases: a systematic review | Q35135179 | ||
| Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 | ||
| The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | Q36728740 | ||
| The pathogenesis of coronary artery disease and the acute coronary syndromes (2). | Q36730913 | ||
| "Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States | Q37561275 | ||
| Economic consequences of severe bleeding in patients with acute coronary syndrome in the USA | Q37778769 | ||
| Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study. | Q38388227 | ||
| Meta-Analysis of Comparison of the Newer Oral P2Y12 Inhibitors (Prasugrel or Ticagrelor) to Clopidogrel in Patients With Non-ST-Elevation Acute Coronary Syndrome | Q38539587 | ||
| P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal use | Q38542096 | ||
| Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose? | Q38557198 | ||
| Temporal trends in acute myocardial infarction: What about survival of hospital survivors? Disparities between STEMI & NSTEMI remain. Soroka acute myocardial infarction II (SAMI-II) project. | Q40241361 | ||
| Comparative Efficacy and Safety of Prasugrel, Ticagrelor, and Standard-Dose and High-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis. | Q40453437 | ||
| Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor | Q40824325 | ||
| An assessment of the validity of ICD Code 410 to identify hospital admissions for myocardial infarction: The Corpus Christi Heart Project | Q41215745 | ||
| 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q44265041 | ||
| One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel | Q45018958 | ||
| Prasugrel versus clopidogrel in patients with acute coronary syndromes | Q46915044 | ||
| Prasugrel vs. clopidogrel in acute coronary syndrome patients treated with prasugrel. | Q51033585 | ||
| The direct and indirect cost burden of acute coronary syndrome. | Q51156671 | ||
| Prasugrel during primary percutaneous coronary intervention: evidence from clinical data. | Q53662491 | ||
| 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol | Q55056448 | ||
| 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines | Q56674421 | ||
| 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention | Q58972787 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 877-887 | |
| P577 | publication date | 2017-05-27 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome | |
| P478 | volume | 37 |
| Q50044401 | Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns an | cites work | P2860 |
Search more.